Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Apremilast may help treat hair loss in alopecia areata.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Tofacitinib treatment is used for teenagers with alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Canakinumab's effect on COVID-19 outcomes is unclear.

The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Sarolaner effectively treated feline demodicosis in a cat.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Retinoids may help treat lupus nephritis and reduce steroid use.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Clobetasol is more effective than metformin for treating localized alopecia areata.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Ruxolitinib can cause a delayed skin reaction on the nose.

Tofacitinib taken by mouth helps treat hair loss in children.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.